Incidental Acute Infarcts Identified on Diffusion-Weighted Images: A University Hospital-Based Study

References

1. ↵
   Hachinski VC, Potter P, Merskey H. Leuko-araiosis. Arch Neurol 1987;44:21–23

   CrossRefPubMedWeb of Science
2. ↵
   Wiszniewska M, Devuyst G, Bogousslavsky J, et al. What is the significance of leukoaraiosis in patients with acute ischemic stroke? Arch Neurol 2000;57:967–73

   CrossRefPubMedWeb of Science
3. ↵
   Chodosh EH, Foulkes MA, Kase CS, et al. Silent stroke in the NINCDS Stroke Data Bank. Neurology 1988;38:1674–79

   Abstract/FREE Full Text
4. Herderschee D, Hijdra A, Algra A, et al. Silent stroke in patients with transient ischemic attack or minor ischemic stroke. The Dutch TIA Trial Study Group. Stroke 1992;23:1220–24

   Abstract/FREE Full Text
5. ↵
   Kase CS, Wolf PA, Chodosh EH, et al. Prevalence of silent stroke in patients presenting with initial stroke: the Framingham study. Stroke 1989;20:850–52

   Abstract/FREE Full Text
6. ↵
   Longstreth WT Jr, Arnold AM, Beauchamp NJ Jr, et al. Incidence, manifestations, and predictors of worsening white matter on serial cranial magnetic resonance imaging in the elderly: the Cardiovascular Health Study. Stroke 2005;36:56–61

   Abstract/FREE Full Text
7. ↵
   Boon A, Lodder J, Raak LH, et al. Silent cerebral infarcts in 755 consecutive patients with first-ever supratentorial ischemic stroke: relationship with index-stroke subtype, vascular risk factors, and mortality. Stroke 1994;25:2384–90

   Abstract/FREE Full Text
8. Chamorro A, Pujol J, Saiz A, et al. Periventricular white matter lucencies in patients with lacunar stroke. A marker of too high or too low blood pressure? Arch Neurol 1997;54:1284–88

   CrossRefPubMedWeb of Science
9. ↵
   Mantyla R, Aronen HJ, Salonen O, et al. Magnetic resonance imaging white matter hyperintensities and mechanism of ischemic stroke. Stroke 1999;30:2053–58

   Abstract/FREE Full Text
10. ↵
    Streifler JY, Eliasziw M, Benavente OR, et al. Development and progression of leukoaraiosis in patients with brain ischemia and carotid artery disease. Stroke 2003;34:1913–16

    Abstract/FREE Full Text
11. ↵
    Nakaji K, Ihara M, Takahashi C, et al. Matrix metalloproteinase-2 plays a critical role in the pathogenesis of white matter lesions after chronic cerebral hypoperfusion in rodents. Stroke 2006;37:2816–23

    Abstract/FREE Full Text
12. Caplan LR. Dilatative arteriopathy (dolichoectasia): what is known and not known. Ann Neurol 2005;57:469–71

    CrossRefPubMedWeb of Science
13. ↵
    Wardlaw JM, Sandercock PA, Dennis MS, et al. Is breakdown of the blood-brain barrier responsible for lacunar stroke, leukoaraiosis, and dementia? Stroke 2003;34:806–12

    Abstract/FREE Full Text
14. ↵
    Brown WR, Moody DM, Challa VR, et al. Apoptosis in leukoaraiosis lesions. J Neurol Sci 2002;203–204:169–71
15. ↵
    Altaf N, Daniels L, Morgan PS, et al. Cerebral white matter hyperintense lesions are associated with unstable carotid plaques. Eur J Vasc Endovasc Surg 2006;31:8–13

    CrossRefPubMedWeb of Science
16. ↵
    Tejada J, Diez-Tejedor E, Hernandez-Echebarria L, et al. Does a relationship exist between carotid stenosis and lacunar infarction? Stroke 2003;34:1404–09

    Abstract/FREE Full Text
17. ↵
    Brun A, Englund E. A white matter disorder in dementia of the Alzheimer type: a pathoanatomical study. Ann Neurol 1986;19:253–62

    CrossRefPubMedWeb of Science
18. ↵
    Warach S. Use of diffusion and perfusion magnetic resonance imaging as a tool in acute stroke clinical trials. Curr Control Trials Cardiovasc Med 2001;2:38–44

    CrossRefPubMed
19. Sorensen AG, Buonanno FS, Gonzalez RG, et al. Hyperacute stroke: evaluation with combined multisection diffusion-weighted and hemodynamically weighted echo-planar MR imaging. Radiology 1996;199:391–401

    CrossRefPubMedWeb of Science
20. Kidwell CS, Alger JR, Saver JL. Beyond mismatch: evolving paradigms in imaging the ischemic penumbra with multimodal magnetic resonance imaging. Stroke 2003;34:2729–35

    Abstract/FREE Full Text
21. ↵
    Knipp SC, Matatko N, Schlamann M, et al. Small ischemic brain lesions after cardiac valve replacement detected by diffusion-weighted magnetic resonance imaging: relation to neurocognitive function. Eur J Cardiothorac Surg 2005;28:88–96

    CrossRefPubMedWeb of Science
22. ↵
    Fellner FA, Fellner C, Aichner FT, et al. Importance of T2*-weighted gradient-echo MRI for diagnosis of cortical vein thrombosis. Eur J Radiol 2005;56:235–39

    CrossRefPubMed
23. Zimmerman RD. Is there a role for diffusion-weighted imaging in patients with brain tumors or is the “bloom off the rose”? AJNR Am J Neuroradiol 2001;22:1013–14

    FREE Full Text
24. ↵
    Stieltjes B, Schluter M, Didinger B, et al. Diffusion tensor imaging in primary brain tumors: reproducible quantitative analysis of corpus callosum infiltration and contralateral involvement using a probabilistic mixture model. Neuroimage 2006;31:531–42

    CrossRefPubMed
25. ↵
    Fazekas F, Kleinert R, Offenbacher H, et al. Pathologic correlates of incidental MRI white matter signal hyperintensities. Neurology 1993;43:1683–89

    Abstract/FREE Full Text
26. ↵
    Auer DP, Putz B, Gossl C, et al. Differential lesion patterns in CADASIL and sporadic subcortical arteriosclerotic encephalopathy: MR imaging study with statistical parametric group comparison. Radiology 2001;218:443–51

    CrossRefPubMedWeb of Science
27. ↵
    de Leeuw FE, de Groot JC, Oudkerk M, et al. Atrial fibrillation and the risk of cerebral white matter lesions. Neurology 2000;54:1795–801

    Abstract/FREE Full Text
28. ↵
    Kobayashi S, Okada K, Koide H, et al. Subcortical silent brain infarction as a risk factor for clinical stroke. Stroke 1997;28:1932–39

    Abstract/FREE Full Text
29. ↵
    Bernick C, Kuller L, Dulberg C, et al. Cardiovascular Health Study Collaborative Research Group. Silent MRI infarcts and the risk of future stroke: the cardiovascular health study. Neurology 2001;57:1222–29

    Abstract/FREE Full Text
30. ↵
    Fisher CM. Lacunes: small, deep cerebral infarcts. Neurology 1965;15:774–84

    FREE Full Text
31. ↵
    Helenius J, Tatlisumak T. Treatment of leukoaraiosis: a futuristic view. Curr Drug Targets 2007;8:839–45

    CrossRefPubMed